Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Sichuan Huiyu Pharmaceutical Co Ltd cash flow reinvestment rate. Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥30.63 Million (capex CN¥30.63 Million ) from operating cash flow of CN¥58.54 Million. See 688553 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Cash flow reinvestment rate of Sichuan Huiyu Pharmaceutical Co Ltd from 2018 to 2024. Historical reinvestment intensity for Sichuan Huiyu Pharmaceutical Co Ltd across 7 annual periods. Explore Sichuan Huiyu Pharmaceutical Co Ltd (688553) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2018–2024)
Sichuan Huiyu Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for Sichuan Huiyu Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Sichuan Huiyu Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.17x | CN¥526.72 Million | CN¥242.96 Million | CN¥128.18 Million | ▼ -82.4% |
| 2023 | 12.35x | CN¥826.75 Million | CN¥66.93 Million | CN¥296.72 Million | ▲ +273.0% |
| 2022 | 3.31x | CN¥642.65 Million | CN¥194.06 Million | CN¥461.61 Million | ▼ -35.9% |
| 2021 | 5.17x | CN¥2.31 Billion | CN¥446.36 Million | CN¥433.45 Million | ▲ +421.4% |
| 2020 | 0.99x | CN¥384.33 Million | CN¥387.95 Million | CN¥158.24 Million | ▼ -16.9% |
| 2019 | 1.19x | CN¥388.90 Million | CN¥326.22 Million | CN¥110.00 Million | ▲ +567.8% |
| 2018 | 0.18x | CN¥23.04 Million | CN¥129.06 Million | CN¥23.04 Million | — |